New Drug Classes for Diabetes Mean New Options

Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.

Source: Medscape Diabetes & Endocrinology Podcast - June 30, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts